Recall Register

Device recall: Cobas infinity central lab IT solution Material Number: 07154003001 Calculator/Data Processing Module, For Clinical Use

Class II FDA enforcement event 82139. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Using the following versions of cobas infinity software (2.0 thorough 2.5), there is a potential where the results from the first sample subsequent to the bottle change, (when using the Standby bottle function), does not display a quality control (QC) alarm when one should be present. If the QC is out of range on the stand-by bottle and it is not removed from the system, there is a potential…

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

Roche Diagnostics Corporation started this device recall on 4 Feb 2019. The firm address in the FDA record is in Indianapolis, IN. FDA put the recall in Class II. FDA event 82139 has 1 product record. The first FDA enforcement report date is 29 May 2019. The record gives the status Terminated, with the termination date 16 Sep 2020. 360 of the 969 device events that started in 2019 have more product records. The median device event of 2019 has 1 product record. The openFDA file has 969 device events that started in 2019 and 1,074 that started in 2018.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

US Distribution to states of: AL, AZ, CA, GA, IA, MO, NJ, NY, SC, TN and TX.

Recalling firm

Roche Diagnostics Corporation, Indianapolis, IN.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 82139: product records
Recall numberProductQuantityClassStatusReport date
Z-1368-2019Cobas infinity central lab IT solution Material Number: 07154003001 Calculator/Data Processing Module, For Clinical Use15 unitsClass IITerminated29 May 2019

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Device events that started in 2019
969
Share of these events in Class II
88%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
26

Other events of the firm

Other FDA enforcement events of Roche Diagnostics Corporation
InitiatedProduct (first record)TypeClassRecords
3 Jun 2019The Tina-quant lgA Gen.2 is an immunoturbidimetric assay. Anti-lgA antibodies react with antigen in the sample to form aDeviceClass II1
4 Apr 2019cobas p 501 post-analytical units, Part Number 05158494001. For diagnostic sample storage and retrieval.DeviceClass III2
18 Mar 2019Albumin BCP Product Usage: ALBP is an in vitro test used for the quantitative determination of albumin in human serum anDeviceClass II1
15 Mar 2019cobas e 801 immunoassay analyzerDeviceClass II1
17 Dec 2018Bilirubin Total Gen.3, Cat. Nos. 05795397190, 05795419190, 05795320160, 05795338160, 05795346160 ***added as of 5/10/19*DeviceClass II3
17 Dec 2018Anti-HAV IgM test System, Material No. 11820591160 Product Usage: The Roche Elecsys Anti-HAV IgM immunoassay is used forDeviceClass II1
14 Dec 2018COBAS INTEGRA 400 plus analyzer used in the following assays: a)Tina-quant Apolipoprotein A-1 ver.2 Catalog Number: 0303DeviceClass II2
24 Sep 2018Roche Diagnostics URISYS 1100 Urine Analyzer Part Number: 03617556001 Product Usage: The URISYS 1100 Urine Analyzer is aDeviceClass II1
13 Sep 2018CoaguChek XS System Prothrombin time test: CoaguChek XS PT Test 2X24 Strips, Catalog Number: 04625315160; CoaguChek XS PDeviceClass I1
16 Jul 2018Roche cobas p 612 pre-analytical system (63x) Model: 07563116001 The cobas p 612 pre-analytical system is a computer conDeviceClass II1

Roche Diagnostics Corporation: all 26 events

Official channels

Cite this page

Recall Register. FDA enforcement event 82139. https://recallregister.com/fda/ii/82139/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA device enforcement reports
Licence
CC0 1.0
Export date
10 Nov 2026
Newest FDA report date on the register
4 Nov 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: US Distribution to states of: AL, AZ, CA, GA, IA, MO, NJ, NY, SC, TN and TX.
What quantity of product is in FDA event 82139?
The FDA record gives this quantity: 15 units
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many device recalls of 2019 have the same class?
88% of the 969 device events that started in 2019 are in Class II.